Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic

Psychosomatics

Volumn 51, Issue 2, 2010, Pages 149-156

  Dieperink, Eric ^a   Ho, Samuel B ^a   Heit, Sara ^a   Durfee, Janet M ^a   Thuras, Paul ^a   Willenbring, Mark L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COUNSELING; TREATMENT RESPONSE;

EID: 77949796775     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.2.149     Document Type: Article

References (39)

1. National Institutes of Health: NIH Consensus Statement on Management of Hepatitis C. NIH Consens State Sci Statements 2002; 19(3):1-46
2. Davis GL, Albright JE, Cook SF, et al: Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9:331-338
3. Wong JB, McQuillan GM, McHutchison JG, et al: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90:1562-1569
4. Poynard T, Bedossa P, Opolen P: Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825-832
5. Monto A, Patel K, Bostrum A, et al: Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39:826-834
6. El-Serag HB, Kunik M, Richardson P, et al: Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002; 123:476-482
7. Nguyen HA, Miller AI, Dieperink E, et al: Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterol 2002; 97:1813-1820
8. Cheung RC: Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000; 95:740-747
9. Fireman M, Indest DW, Blackwell A, et al: Addressing trimorbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005; 40(Suppl 5):S286-S291
10. Muir AJ, Provenzale D: A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol 2002; 24:268-271
11. Cawthorne CH, Rudat KR, Burton MS, et al: Limited success of HCV antiviral therapy in United States veterans. Am J Gastro-enterol 2002; 97:149-155
12. Falck-Ytter Y, Kale H, Mullen KD, et al: Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136:288-292
13. Oshita M, Hayashi N, Kasahara A, et al: Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20:1115-1120
14. Regev A, Jeffers LJ: Hepatitis C and alcohol. Alcohol Clin Exp Res 1999; 23:1543-1551
15. Schiff ER: The alcoholic patient with hepatitis C virus infection. Am J Med 1999; 107(6B):95S-99S
16. Sherman KE, Mendenhall C, Thee DL, et al: Hepatitis C serotypes in nonalcoholic and alcoholic patients. Dig Dis Sci 1997; 42:2285-2291
17. Willenbring ML: Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 2005; 19(suppl 3):S227-S237
18. Kristenson H, Ohlin H, Hultén-Nosslin MB, et al: Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls. Alcohol Clin Exp Res 1983; 7:203-209
19. Lieber CS, Weiss DG, Groszmann R, et al: I: Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res 2003; 27:1757-1764
20. Willenbring ML, Olson DH: A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med 1999; 159:1946-1952
21. Bush K, Kivlahan DR, McDonell MB, et al: The Audit Alcohol Consumption questions (AUDIT - C): an effective brief screening test for problem drinking: Ambulatory Care Quality Improvement Project (ACQUIP) Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158:1789-1795
22. Beck AT, Beamesderfer A: Assessment of depression: The Depression Inventory. Mod Probl Pharmacopsychiatry 1974; 7:151-169
23. Prins A: The Primary Care PTSD Screen (PC - PTSD): development and operating characteristics. Primary Care Psychiatry 2003; 9:9-14
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Washington, DC, American Psychiatric Association, 1994
25. Bien TH, Miller WR, Tonigan JS: Brief interventions for alcohol problems: a review. Addiction 1993; 88:315-335
26. National Institute on Alcohol Abuse and Alcoholism: Motivational Enhancement Therapy Manual, Vol 2. NIH Pub. No. 94-3723, 1994, p 121
27. National Institute on Alcohol Abuse and Alcoholism, Cognitive - Behavioral Coping Skills Therapy Manual, Vol 3. NIH Pub. No. 94-3724, 1995, p 101
28. Anand BS: Recent alcohol use but not prior alcohol use influences hepatitis C antiviral treatment adherence and outcomes: results of a national multicenter study. Hepatology 2004; 40: 316A-317A
29. Peltekian K: Predictability of an early virologic response with Peginterferon alfa-2a (40KD) plus ribavirin in the "real world:" results of a multicentre open-label expanded access program for patients with chronic hepatitis C in Canada. Gastroenterology 2005; 128:A721
30. Younossi ZM, McCullough AC, Barnes DS, et al: Pegylated interferon alpha-2b, ribavirin, and amantadine for chronic hepatitis C. Dig Dis Sci 2005; 50:970-975
31. Whitlock EP, Polen MR, Green CA, et al: Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for The U.S. Preventive Services Task Force. Ann Intern Med 2004; 140:557-568
32. Rifai MA, Moles JK, Lehman LP, et al: Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Psychosomatics 2006; 47:112-121
33. Bini EJ, Bräu N, Currie S, et al: Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100:1772-1779
34. Loguercio C, Di Pierro M, Di Marino MP, et al: Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological, and pathological aspects. Alcohol Alcohol 2000; 35:296-301
35. Ohnishi K, Matsuo S, Matsutani K, et al: Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996; 91:1374-1379
36. Okazaki T, Yoshihara H, Suzuki K, et al: Efficacy of interferon therapy in patients with chronic hepatitis C: comparison between non-drinkers and drinkers. Scand J Gastroenterol 1994; 29:1039-1043
37. Backmund M, Meyer K, Von Zielonka M, et al: Treatment of hepatitis C infection in injection drug users. Hepatology 2001; 34:188-193
38. Sylvestre DL: Treating hepatitis C virus infection in active substance users. Clin Infect Dis 2005; 40(Suppl 5):S321-S324
39. Del Boca FK, Darkes J: The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 2003; 98(Suppl 2):1-12